Abstract
Purpose Explore the potential role of a social contagion factor of opioid use disorder by attempting to replicate the exponential rise in opioid overdose mortality rates using agent-based simulation modeling.
Methods We utilized an agent-based simulation model built using the Framework for Reconstructing Epidemiological Dynamics software to implement the social contagion component. This updated model was run in Allegheny County for a 21-year period for this pilot study.
Results The opioid overdose death rate trend was closely replicated by adding the social contagion component to our model.
Limitations The original model does not account for individual-specific risk factors. Furthermore, our model does not capture the effect of a social contagion on success in treatment.
Conclusions Our findings show that a social contagion component of opioid use disorder is potentially important in understanding the driving factors behind the exponential increase in opioid overdose death rates. There are likely other factors that are also partly responsible for these trends.
Implications Social contagion could help explain the trends in opioid epidemic, but more research is warranted to understand its interaction with other factors, such as age, sex, race, opioid prescription rate etc.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a CDC contract
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos